Biolocus Pharma Private Limited
About Biolocus Pharma Private Limited
Data last updated:
Biolocus Pharma Private Limited is a private limited company based in Delhi, India. It operates in the specialized hospitals segment of the healthcare sector. It was incorporated on 22 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85110DL2021PTC388668.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Ateeq Ur Rehman and Mohammad Imran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 98 3rd Floor Abul Fazal Enclave – I Jamia Nagar Okhla, Delhi, India – 110025.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.99 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹33,786 (net margin 2.1%) and EBITDA of ₹82,332 (EBITDA margin 5.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 98 3rd Floor Abul Fazal Enclave – I Jamia Nagar Okhla, Delhi, India – 110025
- IndustryHealthcare, Specialized Hospitals, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Biolocus Pharma Private Limited
The main business activity of Biolocus Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Biolocus Pharma Private Limited FY 2025 filings available
Biolocus Pharma Private Limited reported revenue of ₹15.99 Lakh (up 3148% YoY) for FY 2024.
Financial Statement Summary of Biolocus Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹82,332 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹33,786 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Biolocus Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.1% | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biolocus Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Biolocus Pharma Private Limited
Biolocus Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A S Tradelink Private Limited | ₹16 Lakh (FY 2018) | •••• | •••• | 133.0% | •••• | New Delhi, Delhi, India |
| Sugam Pharmaceuticals Private Limited | ₹16 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Muktsar, Punjab, India |
| Kvati Healthcare Private Limited | ₹16 Lakh (FY 2024) | •••• | •••• | 49.0% | •••• | Dehradun, Uttarakhand, India |
| Sanguine Safety System Private Limited | ₹16 Lakh (FY 2024) | •••• | •••• | -31.0% | •••• | Ahmedbada, Gujarat, India |
| Trimiti's Arts N Graphics Private Limited | ₹15.99 Lakh (FY 2024) | •••• | •••• | •••• | Sangli, Maharashtra, India | |
| Biolocus Pharma Private Limited this company | ₹15.99 Lakh (FY 2024) | •••• | •••• | 3148.0% | •••• | Delhi, India |
| Sarawgiji Foods Private Limited | ₹15.99 Lakh (FY 2017) | •••• | •••• | 534.0% | •••• | Dabra, Madhya Pradesh, India |
| Apollo Textile Mills Private Limited | ₹15.99 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Rajasthan, India |
| Blueair India Private Limited | ₹15.98 Lakh (FY 2023) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Unitedstars Solutions Private Limited | ₹15.98 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Raipur, Chhattisgarh, India |
| Jubilee Commotrade Private Limited | ₹15.98 Lakh (FY 2017) | •••• | •••• | 13898.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Biolocus Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Biolocus Pharma Private Limited
Biolocus Pharma Private Limited is audited by MOHD NAVED for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MOHD NAVED | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Biolocus Pharma Private Limited
Biolocus Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ateeq Ur Rehman | Director | 22 Oct 2021 | 4 Years 11 Months | Current |
| Mohammad Imran | Director | 22 Oct 2021 | 4 Years 11 Months | Current |
| Mohammed Danish Abdul Wahab | Director | 05 Dec 2022 | 3 Years 10 Months | Current |
Ownership and Shareholding of Biolocus Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Biolocus Pharma Private Limited
Biolocus Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Biolocus Pharma Private Limited
Biolocus Pharma Private Limited has a workforce of 0 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Biolocus Pharma Private Limited
Biolocus Pharma Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Mohammed Danish Abdul Wahab was appointed as Director on 05 Dec 2022.
Credit Ratings, Litigation & Regulatory Alerts for Biolocus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biolocus Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biolocus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Biolocus Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biolocus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolocus Pharma Private Limited
Biolocus Pharma is an active private limited company based in Delhi, India. The company works in specialized hospitals, within the healthcare industry. It was incorporated on 22 October 2021 (5+ years old) and is registered under CIN U85110DL2021PTC388668.
Biolocus Pharma reported revenue of ₹15.99 Lakh for FY 2024 (up 3148% YoY).
Biolocus Pharma has 3 current directors:
- Ateeq Ur Rehman - Director
- Mohammad Imran - Director
- Mohammed Danish Abdul Wahab - Director
Biolocus Pharma reported a net profit of ₹33,786 (net margin 2.1%) and EBITDA of ₹82,332 (EBITDA margin 5.1%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Biolocus Pharma is U85110DL2021PTC388668. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biolocus Pharma was incorporated on 22 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biolocus Pharma by revenue are A S Tradelink Private Limited, Sugam Pharmaceuticals Private Limited, Kvati Healthcare Private Limited, Sanguine Safety System Private Limited, Trimiti's Arts N Graphics Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Mohammed Danish Abdul Wahab was appointed as Director on 05 Dec 2022. Ateeq Ur Rehman was appointed as Director on 22 Oct 2021. Mohammad Imran was appointed as Director on 22 Oct 2021.
The registered office of Biolocus Pharma is at D – 98 3rd Floor Abul Fazal Enclave – I Jamia Nagar Okhla, Delhi, India – 110025.
Biolocus Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.
Biolocus Pharma operates in the healthcare industry, in the specialized hospitals segment.